Pay in 4 interest-free payments of $6.77 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
2 The 28.7% figure is the largest average weight loss reported in any Phase 3 obesity trial so far
A 52-week clinical trial where dulaglutide was given to 1,842 patients with a mean BMI of 34.2 found that all three doses tested resulted in significant reductions in body weight from baseline at the 36week mark
Understanding these patterns helps protect you from this product and the dozens of similar ones flooding the market
At Set Point Medical Weight Loss Clinic, we believe in a holistic approach to managing type 2 diabetes, considering all aspects of well-being, including exercise, nutrition, stress management, and advanced treatments like Tirzepatide
"Efficacy and Safety of Semaglutide Versus Dulaglutide as add-on to Metformin in Subjects With Type 2 Diabetes
US$ 24.37
US$ 27.64
US$ 22.03
US$ 22.34
US$ 25.61
US$ 25.02
US$ 21.91
US$ 22.85
